Our Vision
An Open and Socially Responsible Healthcare Group
Our Vision
OSR Holdings, an Open and Socially Responsible Healthcare Group
Simplification Through Innovation
OSR Holdings brings together a diversified portfolio of subsidiary companies spanning immuno-oncology, biologics, MedTech, and device distribution. This diversity not only reduces reliance on any single technology, modality, or manufacturing pathway, but also allows each program to navigate distinct global regulatory frameworks, further mitigating risk across the portfolio.
What unites us is our singular strategic focus: making healthcare simpler, more accessible, and less burdensome. By aligning our platforms around this vision, we deliver meaningful impact for patients, streamline care for healthcare providers, and create lasting benefits for society as a whole. Simplification through innovation.
OSR Holdings brings together a diversified portfolio of subsidiary companies spanning immuno-oncology, biologics, MedTech, and device distribution. This diversity not only reduces reliance on any single technology, modality, or manufacturing pathway, but also allows each program to navigate distinct global regulatory frameworks, further mitigating risk across the portfolio.
What unites us is our singular strategic focus: making healthcare simpler, more accessible, and less burdensome. By aligning our platforms around this vision, we deliver meaningful impact for patients, streamline care for healthcare providers, and create lasting benefits for society as a whole. Simplification through innovation.
Impact in Action
Examples of lead programs that aim to achieve OSR Holdings vision of simplifying healthcare:
VXM01: From IV to Oral Dosing →
- Replacing complex hospital infusions with an oral vaccine. Cheaper, easier, scalable
DRT-101: From Surgery to Pill →
- Disease-modifying drug to prevent major invasive joint replacement surgeries
Glucheck: From Pain to Passive →
- Non-invasive monitoring eliminates the pain and burden of daily finger pricks
4PL: From Fragmented to Integrated →
- Reducing regulatory, financial and logistical complexity in medical device distribution
Impact in Action
Examples of lead programs that aim to achieve OSR Holdings vision of simplifying healthcare:
VXM01: From IV to Oral Dosing →
- Replacing complex hospital infusions with an oral vaccine. Cheaper, easier, scalable
DRT-101: From Surgery to Pill →
- Disease-modifying drug to prevent major invasive joint replacement surgeries
Glucheck: From Pain to Passive →
- Non-invasive monitoring eliminates the pain and burden of daily finger pricks
4PL: From Fragmented to Integrated →
- Reducing regulatory, financial and logistical complexity in medical device distribution
OSR Holdings Reg No. 589-86-01485
Email. group@osr-holdings.com
US: 10900 NE 4th Street, 2300 Bellevue, WA 98004
KR: B-dong, 3F, 37-36 Hoedong-gil, Paju-si, Gyeonggi-do
CH: Technologiepark Basel, Hochbergerstrasse 60c
Copyright © OSR Holdings, Inc. All Rights Reserved.
OSR Holdings, Inc. Reg No. 589-86-01485 Email. group@osr-holdings.com
U.S 10900 NE 4th Street, 2300 Bellevue, WA 98004
Korea, Republic of B-dong, 3F, 37-36 Hoedong-gil, Paju-si, Gyeonggi-do
Switzerland Technologiepark Basel, Hochbergerstrasse 60c, CH-4057
Copyright © OSR Holdings, Inc. All Rights Reserved.
